Over the past three years, the FDA has received more than 1,000 reports from nine different surgical mesh manufacturers of complications with their devices

1. Bard Avaulta Infection and Dangers

2. Over the past three years, the FDA has received more than
1,000 reports from nine different surgical mesh
manufacturers of complications with their devices. These
devices, used to repair Pelvic Organ Prolapse and Stress
Urinary Incontinence, were introduced on the market to
alleviate the pain and discomfort experienced by the
women suffering from these conditions, however the FDA
reports suggest otherwise.

3. Surgical mesh functions by supporting the bladder, and
reinforcing the muscles that control the flow of urine from
the body for treatment of Stress Urinary Incontinence. For
prolapse, the mesh acts as a barrier to hold the pelvic
organs in place, preventing any painful slipping from their
normal place in the pelvis. The mesh is inserted through
the vagina for both of these procedures, using minimally
invasive techniques.

4. What is proving to not be minimally invasive are the serious
side effects being reported by patients who have had this
surgery performed. Complications being reported include
erosion of vaginal tissue, pain, and additional urinary
problems. Visit Avaulta vaginal mesh for more info. The
most common complication reported to the FDA is serious
infection.

5. Infections from transvaginal placement of surgical mesh
can occur in one of two ways. First, an infection may be
caused by bowel, bladder, or blood vessel perforation,
which occurs during insertion of the surgical mesh. Second,
the mesh design may inhibit surrounding tissue from
receiving nutrients and oxygen, causing impaired healing
that can lead to an infection.

6. A surgical mesh recall has not yet been issued for Bard
Avaulta or other surgical mesh devices, as the FDA has not
yet determined whether specific characteristics put some
patients at an increased risk for transvaginal surgical mesh
infection. Some contributing factors to complications include
the patient's overall health, the transvaginal surgical mesh
material, the size and shape of the surgical mesh, the
surgical technique used, concomitant procedures
undertaken (e.g. hysterectomy), and possibly estrogen
status.
http://www.consumerinjuries.com/avaulta-vaginal-
mesh/

7. A surgical mesh recall has not yet been issued for Bard
Avaulta or other surgical mesh devices, as the FDA has not
yet determined whether specific characteristics put some
patients at an increased risk for transvaginal surgical mesh
infection. Some contributing factors to complications include
the patient's overall health, the transvaginal surgical mesh
material, the size and shape of the surgical mesh, the
surgical technique used, concomitant procedures
undertaken (e.g. hysterectomy), and possibly estrogen
status.
http://www.consumerinjuries.com/avaulta-vaginal-
mesh/